Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
View Menu

Investor information

Keeping our shareholders and potential investors informed about recent news, share price, and other relevant information


Essential information for our Shareholders

For any queries regarding your shareholding, please contact Equiniti on
0371-384-2030 (UK), or +44 (0)121-415-7047 (Overseas). Lines are open Monday to Friday 8.30am to 5.30pm (UK time); excluding UK Bank Holidays.

Alternatively, you can manage and maintain your shareholding at

Significant shareholders

The Company has been made aware of the following significant (3% or greater) shareholdings in the Company’s ordinary shares:

Percentage of Share Capital
Lord Drayson* 23.8%
Lansdowne Partners 9.7%
Acacia Research Corporation 9.5%
Baillie Gifford & Co 7.9%
Sand Grove Capital Management 6.8%
Gatemore Capital Management 6.1%
Amati 3.6%
OUH NHS Foundation Trust 3.6%

*Including related parties

The above information was last updated on 01/03/2021

Analyst coverage

Please see below for information on the analysts covering Sensyne Health

List of analysts, their respective institutions, and position.

Links to analysts’ reports publicly available

Shareholders Meetings

The 2020 Annual General Meeting was held on 30 October 2020. The Notice of the Annual General Meeting and the ordinary and special resolutions proposed at the meeting can be found below. All resolutions proposed at the Annual General Meeting were duly passed.

The Company held a General Meeting on 4 January 2021 in connection to a placing, subscription and open offer of new ordinary shares. The Circular and Notice of the General Meeting detailing the ordinary and special resolutions proposed at the meeting can be found below. All resolutions proposed at the General Meeting were duly passed enabling the placing, subscription and open offer to close on 5 January 2021.

Date Document name Link
6 Oct 2020 Notice of the 2020 AGM Download
4 Jan 2021 Notice of the 2021 GM Download

Share fraud warning

Share fraud may include scams in which investors are contacted unexpectedly and offered shares that often turn out to be worthless or non-existent, or an inflated price for shares they own. These calls come from fraudsters who are mostly based abroad and they can be very persistent and extremely persuasive.

The Financial Conduct Authority (FCA) reported that the average amount lost by investors is around £20,000 each year.

It is not just the novice investor that is at risk; many of the victims had been successfully investing for several years. Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount or offers of free company reports.

Helpful numbers:
FCA website:
FCA consumer helpline: 0800 111 6768
Action Fraud website:
Action Fraud helpline: 0300 123 2040